Crestwood Advisors Group LLC bought a new position in Monogram Orthopaedics Inc. (NASDAQ:MGRM – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 10,000 shares of the company’s stock, valued at approximately $29,000.
Separately, Focus Partners Advisor Solutions LLC grew its position in shares of Monogram Orthopaedics by 6.1% during the first quarter. Focus Partners Advisor Solutions LLC now owns 213,678 shares of the company’s stock worth $628,000 after acquiring an additional 12,328 shares during the last quarter. 0.45% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Monogram Orthopaedics in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, Monogram Orthopaedics presently has a consensus rating of “Moderate Buy” and an average price target of $5.40.
Monogram Orthopaedics Stock Performance
NASDAQ:MGRM opened at $6.00 on Friday. The stock has a market cap of $243.79 million, a price-to-earnings ratio of -12.00 and a beta of 0.68. Monogram Orthopaedics Inc. has a 1 year low of $1.92 and a 1 year high of $6.43. The business has a fifty day moving average of $5.93 and a 200-day moving average of $4.56.
Monogram Orthopaedics (NASDAQ:MGRM – Get Free Report) last issued its quarterly earnings data on Friday, August 15th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.05). On average, equities research analysts predict that Monogram Orthopaedics Inc. will post -0.49 EPS for the current year.
About Monogram Orthopaedics
Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Further Reading
- Five stocks we like better than Monogram Orthopaedics
- What to Know About Investing in Penny Stocks
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- 3 Best Fintech Stocks for a Portfolio Boost
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Profitably Trade Stocks at 52-Week Highs
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Want to see what other hedge funds are holding MGRM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monogram Orthopaedics Inc. (NASDAQ:MGRM – Free Report).
Receive News & Ratings for Monogram Orthopaedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monogram Orthopaedics and related companies with MarketBeat.com's FREE daily email newsletter.
